Search This Blog:    HIV   MPOX

DeutschEspañolFrançaisItaliano

 


GSK snags first-in-class FDA nod for Rukobia to treat HIV patients who have few options

Rukobia, a first-in-class attachment inhibitor by GlaxoSmithKline's ViiV Healthcare, has won FDA approval to treat multidrug-resistant HIV. (Business ...


View article...

Top stories of the last 30 days